18311-29-0

Upstream product

• 98-88-4 benzoyl chloride 
• 5965-66-2 LACTOSE 

Downstream Products

• 1392399-99-3 ethyl 2,3,6-tri-O-benzoyl-4-O-(2,3,4,6-tetra-O-benzoyl-β-D-galactopyranosyl)-1-thio-α-D-glucopyranoside 
• 201296-54-0 ethyl 2,3,6-tri-O-benzoyl-4-O-(2,3,4,6-tetra-O-benzoyl-β-D-galactopyranosyl)-1-thio-β-D-glucopyranoside 
• 18311-30-3 2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl-(1→4)-2,3,6-tri-O-benzoyl-α-D-glucopyranosyl bromide 
• 736969-78-1 2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl-(1-4)-1,2,3,6-tetra-O-benzoyl-D-glucopyranosyl trichloroacetimidate 
• 773145-61-2 2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl-(1->4)-2,3,6-tri-O-benzoyl-α-D-glucopyranosyl trichloroacetimidate 

Relevant academic research and scientific papers

GLYCOSIDE COMPOUND AND PREPARATION METHOD THEREFOR, COMPOSITION, APPLICATION, AND INTERMEDIATE

The present invention discloses a glycoside compound represented by Formula III, and a preparation method, a composition, use and an intermediate thereof. The glycoside compound provided in the present invention has simple preparation method, can significantly increase the expression of VEGF-A mRNA, and is effective in promoting the angiogenesis. This provides a reliable guarantee for the development of drugs with pro-angiogenic activity for treating cerebral infarction cerebral stroke, myocardial infarction, and ischemic microcirculatory disturbance of lower limbs.

DISSACHARIDE FORMULATIONS FOR CONTROLLED DRUG RELEASE

The present invention relates to a composition comprising non-water soluble dissacharides and oil, a solvent and at least one pharmaceutical ingredient, wherein the composition contains at least two compounds selected from saccharides and lipid oils such